Status:

UNKNOWN

Chewing Gum Test for the Diagnosis of Giant Cell Arteritis (Horton's Disease) - ChewingHort

Lead Sponsor:

University Hospital, Limoges

Conditions:

Horton Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

It is hypothesized that chewing-gums may be a useful test to unmask jaws intermittent claudication in order to enhance the diagnosis of Giant Cell Arteritis (GCA).

Detailed Description

GCA is the most common vasculitis. The diagnosis easily could be made in patients over 50 years old with headache, inflammatory belt pain, claudication of the jaws, scalp hyperesthesia, ophthalmologic...

Eligibility Criteria

Inclusion

  • Group 1
  • Any patient suspected of having GCA, that is to say in practice patients in whom a doctor plans a Doppler ultrasound of temporal arteries or a temporal arteritis biopsy or an imagery (Angio-CT, Angio-MRI, PET- to scan
  • Patient over 50 years old
  • Patient able to chew a chewing gum for 4 minutes Group 2
  • Patients free from GCA
  • Age matched (± 3 years)
  • Patient able to chew a chewing gum for 4 minutes

Exclusion

  • Group 1
  • Patients known to have a temporomandibular joint pathology
  • Patients who started corticosteroid therapy Group 2
  • Patients known to have temporomandibular joint pathology
  • Patients who started corticosteroid therapy

Key Trial Info

Start Date :

October 30 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2022

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT04010097

Start Date

October 30 2019

End Date

January 1 2022

Last Update

November 17 2021

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

CH Avignon

Avignon, France

2

CHU Limoges

Limoges, France

3

CHU de Nantes

Nantes, France

4

CH St Antoine

Paris, France